NIH-funded research R01 grant

Understanding Pulmonary Sarcoidosis with Protein Signatures

Official title: Comprehensive Proteomic Classifier for the Molecular Characterization of Pulmonary Sarcoidosis

Funded at Ohio State University · NIH-11293906 · Data updated 2026-11-12

This project aims to find unique protein patterns in people with pulmonary sarcoidosis to help doctors better understand and treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startAugust 15, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$517,232
NIH project number7R01HL153613-05
Project IDNIH-11293906 on NIH RePORTER

Who could benefit from this research

Could help

This research is relevant for individuals living with pulmonary sarcoidosis, particularly those whose disease progression is uncertain or challenging to manage.

Less likely to help

Patients without pulmonary sarcoidosis or those whose disease is already stable and well-understood may not directly benefit from this specific diagnostic tool development.

What this research studies

Sarcoidosis is a complex immune disease that can be hard to diagnose and treat, especially when it affects the lungs. Currently, treatments often involve general immune suppression with side effects. Our team is looking for specific protein changes in the lungs and blood that could act as markers for sarcoidosis and help predict if the disease will get worse. By identifying these protein "signatures," we hope to develop new tools for more precise diagnosis and personalized treatment strategies. This could lead to better outcomes and fewer side effects for patients.

Why it matters

Potential benefit: If successful, this work could lead to new ways to diagnose pulmonary sarcoidosis more accurately and predict its progression, allowing for more targeted and effective treatments.

How similar studies have gone: While previous work has identified genetic changes related to progressive sarcoidosis, this project focuses on protein changes, which are the direct effectors of cell function, offering a novel approach building on preliminary data.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Bhargava, Maneesh — Ohio State University
  • Study coordinator: Bhargava, Maneesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.